Class I Recalls of Cardiovascular Devices Between 2013 and 2022 : A Cross-Sectional Analysis.
PMID : 39284187 ·
C, l, a, u, d, i, a, , S, e, e, ;, , M, a, r, y, a, m, , M, o, o, g, h, a, l, i, ;, , S, a, n, k, e, t, , S, , D, h, r, u, v, a, ;, , J, o, s, e, p, h, , S, , R, o, s, s, ;, , H, a, r, l, a, n, , M, , K, r, u, m, h, o, l, z, ;, , K, u, s, h, a, l, , T, , K, a, d, a, k, i, a
Publicité
Résumé
Cardiovascular devices account for one third of all Class I recalls, the U.S. Food and Drug Administration's (FDA) most severe designation, indicating a reasonable probability of "serious adverse health consequences or death." Understanding recalls and their causes is important for patient safety. To characterize Class I recalls of cardiovascular devices and the clinical evidence supporting authorization. In this cross-sectional study, cardiovascular device recalls from 1 January 2013 through 31
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.